In a mouse breast cancer model, Jackson et al. reported that p53 wild-type tumors, unlike mutant p53 tumors, undergo senescence in response to chemotherapy, avoiding abnormal mitoses and cell death74. This evidence concerns the gene TP53 and breast carcinoma.